Effect of low dose robotic-gait training on walking capacity in children and adolescents with cerebral palsy.

Cerebral palsy Gait analysis Muscle strength Robotic rehabilitation Walking abilities

Journal

Neurophysiologie clinique = Clinical neurophysiology
ISSN: 1769-7131
Titre abrégé: Neurophysiol Clin
Pays: France
ID NLM: 8804532

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 04 06 2020
revised: 04 09 2020
accepted: 05 09 2020
pubmed: 5 10 2020
medline: 16 9 2021
entrez: 4 10 2020
Statut: ppublish

Résumé

Robotic gait training presents a promising training modality. Nevertheless, evidence supporting the efficacy of such therapy in children with cerebral palsy remains insufficient. This study aimed to assess the effect of robotic gait training in children/adolescents with cerebral palsy. Twenty-four children/adolescents with bilateral cerebral palsy (12 female, 10.1 ± 3.1 years, Gross Motor Function Classification System II to IV) took part in this study. They received two 30-45 min sessions/week of Lokomat training for 12-weeks. Muscle strengths, 6-min walk exercise and gait parameters were evaluated pre- and post-training and at 6-months-follow-up. Training effect according to the level of impairment severity (moderate vs severe) was analyzed using a change from the baseline procedure. A significant increase in muscle strength was observed after training (p ≤ 0.01). Hip flexors and knee extensors strength changes were maintained or improved at follow-up (p < 0.05). Comfortable walking speed was significantly increased by +20% after training with a slight reduction at follow-up compared to post-training condition (-2.7%, p < 0.05). A significant step length increase was observed after training (14%, p ≤ 0.001). The distance covered in 6 min was higher in post-training (+24%, p ≤ 0.001) and maintained at follow-up compared to pre-training conditions. No significant changes in kinematic patterns were observed. The analysis by subgroup showed that both groups of children (with moderate and severe impairments) improved muscle strength and walking capacities after Lokomat training. The suggested Lokomat training induced improvement in walking capacity of children/adolescents with cerebral palsy whatever the level of severity. Hence, Lokomat training could be viewed as a valuable training modality in this population.

Identifiants

pubmed: 33011059
pii: S0987-7053(20)30102-7
doi: 10.1016/j.neucli.2020.09.005
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

507-519

Informations de copyright

Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Auteurs

Yosra Cherni (Y)

École de Kinésiologie et des Sciences de L'Activité Physique, Faculté de Médecine, Université de Montréal, 2100, Boul. Édouard-Montpetit, H3T 1J4 Montréal, Québec, Canada; Centre de Recherche du Centre de Réadaptation Marie-Enfant, CHU Sainte-Justine, 5200 Rue Bélanger, H1T 1C9 Montréal, Québec, Canada. Electronic address: yosra.cherni@umontreal.ca.

Laurent Ballaz (L)

Centre de Recherche du Centre de Réadaptation Marie-Enfant, CHU Sainte-Justine, 5200 Rue Bélanger, H1T 1C9 Montréal, Québec, Canada; Département des Sciences de L'Activité Physique, Université de Québec à Montréal, C.P. 8888, Succursale Centre-Ville, H3C 3P8 Montréal, Québec, Canada.

Josiane Lemaire (J)

Centre de Recherche du Centre de Réadaptation Marie-Enfant, CHU Sainte-Justine, 5200 Rue Bélanger, H1T 1C9 Montréal, Québec, Canada.

Fabien Dal Maso (F)

École de Kinésiologie et des Sciences de L'Activité Physique, Faculté de Médecine, Université de Montréal, 2100, Boul. Édouard-Montpetit, H3T 1J4 Montréal, Québec, Canada.

Mickael Begon (M)

École de Kinésiologie et des Sciences de L'Activité Physique, Faculté de Médecine, Université de Montréal, 2100, Boul. Édouard-Montpetit, H3T 1J4 Montréal, Québec, Canada; Centre de Recherche du Centre de Réadaptation Marie-Enfant, CHU Sainte-Justine, 5200 Rue Bélanger, H1T 1C9 Montréal, Québec, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH